CFH and CFHR structural variants in atypical Hemolytic Uremic Syndrome: Prevalence, genomic characterization and impact on outcome
IntroductionAtypical hemolytic uremic syndrome (aHUS) is a rare disease that manifests with microangiopathic hemolytic anemia, thrombocytopenia, and acute renal failure, and is associated with dysregulation of the alternative complement pathway. The chromosomal region including CFH and CFHR1-5 is ri...
Main Authors: | Rossella Piras, Elisabetta Valoti, Marta Alberti, Elena Bresin, Caterina Mele, Matteo Breno, Lucia Liguori, Roberta Donadelli, Miriam Rigoldi, Ariela Benigni, Giuseppe Remuzzi, Marina Noris |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-01-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.1011580/full |
Similar Items
-
Pediatric Atypical Hemolytic Uremic Syndrome Advances
by: Rupesh Raina, et al.
Published: (2021-12-01) -
Application of eculizumab, a terminal complement inhibitor, in the management of atypical hemolytic uremic syndrome in a 14-month-old Chinese pediatric patient: a case report
by: Xin Wei, et al.
Published: (2024-07-01) -
Pregnancy-Associated Atypical Hemolytic Uremic Syndrome: A Case Report with <i>MCP</i> Gene Mutation and Successful Eculizumab Treatment
by: Alex Domínguez-Vargas, et al.
Published: (2024-01-01) -
An ex vivo test to investigate genetic factors conferring susceptibility to atypical haemolytic uremic syndrome
by: Sara Gastoldi, et al.
Published: (2023-02-01) -
Anti-factor H antibody and its role in atypical hemolytic uremic syndrome
by: Rupesh Raina, et al.
Published: (2022-08-01)